Yahoo Web Search

Search results

1. • 

     Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease...

     Benzinga via Yahoo Finance· 22 hours ago

     On Thursday, Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) released topline results from its...

2. • 

     AbbVie buyout Cerevel marks trial win for Parkinson’s drug

     Seeking Alpha· 1 day ago

     AbbVie's (ABBV) buyout target, Cerevel Therapeutics (CERE), announced positive data for its...

3. • A company insider recently sold 50,000 shares of Cerevel Therapeutics Holdings Inc [CERE]. Should...

     Knox Daily· 1 day ago

     As published in a research note from TD Cowen on December 08, 2023, Cerevel Therapeutics Holdings Inc [CERE] has been rated down from an Outperform to a Market perform and ...

4. • Arizona State Retirement System Has $840,000 Holdings in Cerevel Therapeutics Holdings, Inc....

     ETF DAILY NEWS· 2 days ago

     Arizona State Retirement System grew its stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report) by 10.9% in the 4th quarter, according to its most recent ...

5. • Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial...

     Morningstar· 1 day ago

     Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced positive topline results ...

6. • Cerevel Therapeutics Sees Unusually Large Options Volume (NASDAQ:CERE)

     ETF DAILY NEWS· 6 days ago

     Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) was the recipient of unusually large options trading activity on Thursday. Stock traders acquired 4,000 ...

7. • Checking in on Cerevel Therapeutics Holdings Inc

     Knox Daily· 4 days ago

     As a result of the transaction, COLES N ANTHONY now holds 15,638 shares, worth roughly $0.65 million. TD Cowen downgraded its Cerevel Therapeutics Holdings Inc [CERE] rating ...

8. • Cerevel's Parkinson's disease drug improves symptom control in late-stage trial

     Reuters· 1 day ago

     , opens new tab said on Thursday its Parkinson's disease drug improved symptom control in patients when tested as an add-on therapy, meeting the main goal in a late-stage study. The trial, which ...

9. • 

     Remembering the life of Pauline Baugh (née Brown)

     Gloucester Daily Times· 9 hours ago

     Pauline "Polly" Smith Baugh (née Brown), 90, of Wayne, PA, passed away peacefully on March 22, 2024. Polly was a kind and sweet woman who was admired for...

10. • 

      Biotech Stock Hits 2024 Low Side Effects In Rabbits Torpedo Schizophrenia Drug

      Investor's Business Daily· 4 days ago

      Neumora Therapeutics (NMRA) said Monday the Food and Drug Administration put its schizophrenia drug...